Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study

Active, not recruitingOBSERVATIONAL
Enrollment

77

Participants

Timeline

Start Date

May 7, 2021

Primary Completion Date

December 18, 2025

Study Completion Date

December 18, 2025

Conditions
Type1 Diabetes
Trial Locations (6)

46202

Indiana University, Indianapolis

55455

University of Minnesota, Minneapolis

64111

Children's Mercy Hospital, Kansas City

80045

Barbara Davis Center, Aurora

94304

Stanford University, Palo Alto

06511

Yale University, New Haven

All Listed Sponsors
collaborator

Juvenile Diabetes Research Foundation

OTHER

collaborator

University of Minnesota

OTHER

lead

Jaeb Center for Health Research

OTHER